24207-38-3

Basic information

• Product Name: N-(2-HYDROXYETHYL)SALICYLAMIDE, 98
• Synonyms: 2-hydroxy-n-(2-hydroxyethyl)-benzamid;2-salicylamidoethanol;n-(2-hydroxyethyl)-salicylamid;n-(beta-hydroxyethyl)salicylamide;s2-2;salicylhydroxyethylamide;salicylicacidethanolamide;N-(2-HYDROXYETHYL)SALICYLAMIDE, 98
• CAS NO: 24207-38-3
• Molecular Formula: C₉H₁₁NO₃
• Molecular Weight: 181.18854
• EINECS: 246-076-0
• Mol File: 24207-38-3.mol
• Article Data: 15

Chemical Properties

• Melting Point: 115-117 °C(lit.)
• Boiling Point: 210-215 °C2 mm Hg(lit.)
• Flash Point: 212.2°C
• Appearance: /
• Density: 1.2375 (rough estimate)
• Vapor Pressure: 2.38E-07mmHg at 25°C
• Refractive Index: 1.5270 (estimate)
• Storage Temp.: -196°C
• CAS DataBase Reference: N-(2-HYDROXYETHYL)SALICYLAMIDE, 98(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-HYDROXYETHYL)SALICYLAMIDE, 98(24207-38-3)
• EPA Substance Registry System: N-(2-HYDROXYETHYL)SALICYLAMIDE, 98(24207-38-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• WGK Germany: 2
• RTECS: VN7490000
• Hazardous Substances Data: 24207-38-3(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Journal of Medicinal Chemistry, 38, p. 130, 1995 DOI: 10.1021/jm00001a018

InChI:InChI=1/C9H11NO3/c11-6-5-10-9(13)7-3-1-2-4-8(7)12/h1-4,11-12H,5-6H2,(H,10,13)

Upstream product

• 141-43-5 ethanolamine 
• 5538-51-2 O-acetylsalicyloyl chloride 
• 119-36-8 methyl salicylate 
• 118-55-8 phenyl Salicylate 
• 118-61-6 2-hydroxy-benzoic acid ethyl ester 
• 69-72-7 salicylic acid 
• 118-91-2 ortho-chlorobenzoic acid 
• 609-65-4 o-chlorobenzoyl chloride 
• 90562-52-0 2-chloro-N-(2-hydroxyethyl)benzamide 
• 61141-14-8 anionic phenyl salicylate 
• 1441-87-8 salicyloyl chloride 
• 623-11-0 1-methyl-4-nitrosobenzene 
• 37592-56-6 salicylic acid-(2-amino-ethyl ester); hydrochloride 
• 606-45-1 2-methoxybenzoic acid methyl ester 

Downstream Products

• 1266619-19-5 2-hydroxy-N-(2-hydroxyethyl)-5-phenylazobenzamide 
• 37592-55-5 N-(2'-Chlorezhyl)-2-hydroxybenzamid 
• 113658-87-0 2,4,6-Trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-[2-(2-hydroxy-benzoylamino)-ethyl] ester 5-[2-(1,1,3-trioxo-1,3-dihydro-1λ⁶-benzo[d]isothiazol-2-yl)-ethyl] ester 
• 92565-10-1 2-(2-salicylamido)ethyl 3-aminocrotonate 
• 143248-63-9 Sinitrodil 
• 115288-98-7 2-(2-salicylamido)ethyl acetoacetate 
• 20237-92-7 2-(2'-Hydroxyphenyl)-2-oxazolin 
• 37592-56-6 salicylic acid-(2-amino-ethyl ester); hydrochloride 

Relevant articles and documents

OXAZOLINE COMPOUND, CROSSLINKER AND RESIN COMPOSITION

PROBLEM TO BE SOLVED: To provide an oxazoline compound and trioxazoline compound optimal as crosslinkers for a wide range of uses, including a coating agent, ink, a film, a binder, and adhesive or the like. SOLUTION: The present invention provides an oxazoline compound represented by the following chemical formula, a trioxazoline compound obtained by trifunctionalizing the oxazoline compound represented by the following chemical formula, and a crosslinker and a resin composition using the oxazoline compound or the trioxazoline compound. In the formula, X is H or R-OH, R is a C1-4 linear or branched alkylene group. SELECTED DRAWING: None COPYRIGHT: (C)2019,JPO&INPIT

New sky-blue and bluish-green emitting Ir(III) complexes containing an azoline ancillary ligand for highly efficient PhOLEDs

Two Ir(III) complexes containing the chromophoric ancillary ligands 2-(4,5-dihydrooxazol-2-yl)phenol and 2-(1-ethyl-4,5-dihydro-1H-imidazol-2-yl)phenol, and a highly functionalized phenylpyridine derivative, 3-(4-(tert-butyl)pyridin-2-yl)-2,6-difluorobenzonitrile, as a cyclometalating ligand were designed and synthesized. The oxazoline/imidazoline heterocycle of the ancillary ligand has the effect of enhancing the metal to ligand charge transfer transition nature of the emitting excited state and the fluorine and cyano substituents on the ligand have enriched the intersystem crossings, as indicated by the experimental photoluminescence analysis. As a result, the oxazoline and imidazoline containing complexes exhibited high photoluminescence quantum yields of about >90% with bright sky-blue emission at 480 nm and bluish-green light at 495 nm, respectively, along with excellent thermal/morphological stability about 400 °C and good solubility, that make them suitable for both wet- and dry-processes. In particular, the phosphorescent OLEDs fabricated by a dry-process showed the maximum EQEs of 21.9% and 19.7% for the oxazoline and imidazoline containing complexes, respectively.

Synthesis of 2H-1,3-benzoxazin-4(3H)-one derivatives containing indole moiety: Their in vitro evaluation against PDE4B

A number of 2H-1,3-benzoxazin-4(3H)-one derivatives containing indole or benzofuran moieties were synthesized by using Pd/C-Cu mediated coupling-cyclization strategy as a key step. The o-iodoanilides or o-iodophenol were coupled with 3-{2-(prop-2-ynyloxy)ethyl}-2H-benzo[e][1,3]oxazin-4(3H)-one using 10%Pd/C-CuI-PPh3 as a catalyst system and Et3N as a base to give the target compounds. All the synthesized compounds were tested for their PDE4B inhibitory potential in vitro using a cell based cAMP reporter assay. Some of them showed fold increase of the cAMP level when tested at 30 μM. A representative compound showed encouraging PDE4B inhibitory properties that were supported by its docking results.